Can NASA and Elon Musk get us to Mars and beyond?

Kymera Therapeutics (NASDAQ:KYMR) used its fourth-quarter 2025 update call to highlight what management described as a “breakout year” driven by clinical progress for its oral STAT6 degrader KT-621, ...

Riverside Resources Inc. (TSXV: RRI) (OTCQB: RVSDF) (FSE: 5YY0) ("Riverside" or the "Company"), is pleased to announce early 2026 assay and porphyry Cu exploration results at the 100%-owned Ariel ...

Strategic aviation app development with intelligent, scalable, and future-ready digital transformation solutions. Our ...